ConvaTec Group PLC (CTEC) Stock Rating Reaffirmed by Goldman Sachs Group Inc

ConvaTec Group PLC (LON:CTEC)‘s stock had its “buy” rating restated by Goldman Sachs Group Inc in a note issued to investors on Thursday, May 4th. They presently have a GBX 310 ($4.00) price target on the stock. Goldman Sachs Group Inc’s price objective would suggest a potential upside of 3.33% from the company’s previous close.

A number of other equities research analysts have also issued reports on the stock. Peel Hunt increased their price objective on shares of ConvaTec Group PLC from GBX 300 ($3.87) to GBX 380 ($4.91) and gave the company a “buy” rating in a report on Thursday, May 4th. HSBC Holdings plc reaffirmed a “buy” rating and set a GBX 330 ($4.26) price objective on shares of ConvaTec Group PLC in a report on Wednesday, April 26th. Numis Securities Ltd reaffirmed a “hold” rating and set a GBX 276 ($3.56) price objective on shares of ConvaTec Group PLC in a report on Tuesday, April 4th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a GBX 305 ($3.94) price objective on shares of ConvaTec Group PLC in a report on Thursday, March 30th. Finally, Royal Bank of Canada increased their price objective on shares of ConvaTec Group PLC from GBX 242 ($3.12) to GBX 278 ($3.59) and gave the company a “sector perform” rating in a report on Thursday, March 23rd. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of GBX 314 ($4.05).

Analyst Recommendations for ConvaTec Group PLC (LON:CTEC)

Shares of ConvaTec Group PLC (LON:CTEC) opened at 300.00 on Thursday. The stock’s 50 day moving average is GBX 292.36 and its 200-day moving average is GBX 255.46. The company’s market cap is GBX 5.78 billion. ConvaTec Group PLC has a one year low of GBX 213.00 and a one year high of GBX 312.90.

TRADEMARK VIOLATION NOTICE: “ConvaTec Group PLC (CTEC) Stock Rating Reaffirmed by Goldman Sachs Group Inc” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://sportsperspectives.com/2017/05/20/convatec-group-plc-ctec-given-buy-rating-at-goldman-sachs-group-inc-updated.html.

ConvaTec Group PLC Company Profile

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

12 Month Chart for LON:CTEC

Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply